IPO registrations (S-1, F-1) · Registrants

PRAECIS PHARMACEUTICALS INC

SEC CIK
1033025 · filings on EDGAR ↗
Registration
Form S-1, first filed 1998-08-12, last 2001-02-14; 3 initial registrations, 9 amendments
Outcome
Final prospectus filed 2000-04-27; withdrawal requested 1999-04-08
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
830 WINTER STREET, Waltham, MA 02451
EIN
04-3200305
EDGAR entity type
operating
Insiders and CEO pay
PRAECIS PHARMACEUTICALS INC on the corporate pages

Offering terms

Proposed price range
$10.00–$12.00 per share (S-1/A filed 2000-04-26)
Final price
$10.00 per share, within the range (424B1 filed 2000-04-27, an initial public offering)
Shares sold
8,000,000
Gross proceeds
$80,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol PRCS
Lead underwriters
Citigroup (3,601,000 shares); CIBC World Markets (1,801,000 shares); Credit Suisse (1,801,000 shares)
Syndicate
ABN AMRO (80,000); Deutsche Bank (80,000); Prudential Securities (80,000); Piper Sandler (80,000); Fahnestock & Co. Inc (53,000); Gerard Klauer Mattison & Co., LLC (53,000); Leerink Partners (53,000); Legg Mason (53,000); Needham & Company (53,000); Parker/Hunter Incorporated (53,000); Truist Securities (53,000); Tucker Anthony Incorporated (53,000)

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 16

FiledFormWhat it isName as filedEDGAR
1998-08-12S-1S-1 (registration)PRAECIS PHARMACEUTICALS INC0001047469-98-030519 ↗
1999-04-08RWRW (withdrawal request)PRAECIS PHARMACEUTICALS INC0000950172-99-000395 ↗
2000-02-08S-1S-1 (registration)PRAECIS PHARMACEUTICALS INC0000912057-00-004383 ↗
2000-03-10S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-00-010882 ↗
2000-03-28S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-00-014079 ↗
2000-03-31S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-00-015446 ↗
2000-04-03S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-00-015781 ↗
2000-04-20S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-00-019046 ↗
2000-04-26S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-00-019677 ↗
2000-04-27424B1424B1 (final prospectus)PRAECIS PHARMACEUTICALS INC0000912057-00-019877 ↗
2001-01-26S-1S-1 (registration)PRAECIS PHARMACEUTICALS INC0000912057-01-002877 ↗
2001-01-31S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-01-003537 ↗
2001-02-12S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-01-004551 ↗
2001-02-14S-1/AS-1/A (amendment)PRAECIS PHARMACEUTICALS INC0000912057-01-005321 ↗
2001-02-14S-1MEFS-1MEF (added securities)PRAECIS PHARMACEUTICALS INC0000912057-01-005903 ↗
2001-02-15424B4424B4 (final prospectus)PRAECIS PHARMACEUTICALS INC0000912057-01-005972 ↗

Prospectus pages read 2

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2000-04-26S-1/Aregistration statement$10.00–$12.008,000,000-Nasdaq PRCS3from the submission text; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3document ↗
2000-04-27424B1final prospectus$10.008,000,000$80,000,000Nasdaq PRCS15from the submission text; price sentence, shares headline, proceeds table, underwriting table 15, cover names 3document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
GEFTER MALCOLM L PHDDirector; Director,OfficerChairman and CSO32006–2007
GARNICK MARC BOfficerEVP and Chief Medical Officer12006
MCLAUGHLIN KEVIN FDirector,OfficerPresident and CEO22006–2007
BAKER G LEONARD JRDirector12007
BOHLIN GAREN GDirector12007
English Edward COfficerVP, CFO, Treasurer & Ass. Sec.12007
MCCANCE HENRY FDirector12007person page Fuzzy
POST LEONARD EDirector12007
WAGNER RICHARD WOfficerEVP, Discovery Research12007
ZENNER PATRICK JDirector12007
SHARROCK DAVID BDirector12007

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Lobbying clientPRAECIS PHARMACEUTICALSMAFederal lobbying (LDA)name and state
Lobbying clientPRAECIS PHARMACEUTICALS INCORPORATEDMAFederal lobbying (LDA)name and state
Patent assigneePraecis Pharmaceuticals, Inc.MAPatents (USPTO)name and state
SEC filerPRAECIS PHARMACEUTICALS INCSEC filers (EDGAR)CIK (EXACT)
Person pageHenry F McCancePeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Pharmaceutical Preparations · Health